| |
Latest 10 SEC filings (by transaction date) for MRNS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 27/24 | Mar 27/24 | Braunstein Scott | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -50,000 | |
Mar 27/24 | Mar 27/24 | Braunstein Scott | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 50,000 | $4.28 |
Feb 22/24 | Feb 20/24 | Shafer Christina | Direct Ownership | Common Stock | S - Open market or private sale | -2,153 | $9.56 |
Feb 22/24 | Feb 20/24 | Manning Martha E | Direct Ownership | Common Stock | S - Open market or private sale | -1,894 | $9.57 |
Feb 21/24 | Feb 16/24 | Hulihan Joseph | Direct Ownership | Common Stock | S - Open market or private sale | -2,814 | $9.98 |
Feb 21/24 | Feb 16/24 | Pfanstiel Steven | Direct Ownership | Common Stock | S - Open market or private sale | -3,092 | $9.97 |
Feb 21/24 | Feb 16/24 | Braunstein Scott | Direct Ownership | Common Stock | S - Open market or private sale | -11,850 | $9.94 |
Jan 19/24 | Jan 18/24 | Noonberg Sarah B. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 20,900 | |
Jan 19/24 | Jan 18/24 | Noonberg Sarah B. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 4,600 | |
Jan 19/24 | Jan 18/24 | Johnson Marvin | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 20,900 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for MRNS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 27/24 | Mar 27/24 | Braunstein Scott | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -50,000 | |
Mar 27/24 | Mar 27/24 | Braunstein Scott | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 50,000 | $4.28 |
Feb 22/24 | Feb 20/24 | Shafer Christina | Direct Ownership | Common Stock | S - Open market or private sale | -2,153 | $9.56 |
Feb 22/24 | Feb 20/24 | Manning Martha E | Direct Ownership | Common Stock | S - Open market or private sale | -1,894 | $9.57 |
Feb 21/24 | Feb 16/24 | Hulihan Joseph | Direct Ownership | Common Stock | S - Open market or private sale | -2,814 | $9.98 |
Feb 21/24 | Feb 16/24 | Pfanstiel Steven | Direct Ownership | Common Stock | S - Open market or private sale | -3,092 | $9.97 |
Feb 21/24 | Feb 16/24 | Braunstein Scott | Direct Ownership | Common Stock | S - Open market or private sale | -11,850 | $9.94 |
Jan 19/24 | Jan 18/24 | Noonberg Sarah B. | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 20,900 | |
Jan 19/24 | Jan 18/24 | Noonberg Sarah B. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 4,600 | |
Jan 19/24 | Jan 18/24 | Johnson Marvin | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 20,900 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Eyepoint Pharmaceuticals (OQ:EYPT) |
AbbVie (N:ABBV) |
Merck & Co (N:MRK) |